The anti-tumor effects of cannabidiol target mitochondria, inducing a significant increase in ROS production and a reduction in anti-inflammatory responses as reflected by a significant decrease in Tumor Necrosis Factor α (TNF-α) expression levels. This evidence concerns the gene TNF and neoplasm.